Staar Surgical (STAA) Cash & Current Investments (2010 - 2026)

Staar Surgical's Cash & Current Investments history runs 17 years deep, the most recent figure standing at $163.9 million for Q2 2026.

• Quarterly Cash & Current Investments fell 26.43% year-over-year to $163.9 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $163.9 million (down 26.43% YoY) and the FY2026 annual result came in at $187.5 million, down 18.64% from the prior year.
• Cash & Current Investments was $163.9 million for Q2 2026 at Staar Surgical, down from $187.5 million in the prior quarter.
• Across five years, Cash & Current Investments topped out at $245.1 million in Q1 2024 and bottomed at $163.9 million in Q2 2026.
• A 5-year average of $207.5 million and a median of $203.8 million in 2023 frame the typical range for Cash & Current Investments.
• Annual changes were most pronounced in 2024 — Cash & Current Investments rose 25.43% — and 2026, when it retreated 26.43%.
• Staar Surgical's Cash & Current Investments stood at $211.6 million in 2022, then grew by 4.29% to $220.7 million in 2023, then grew by 4.43% to $230.5 million in 2024, then fell by 16.41% to $192.7 million in 2025, then declined by 14.93% to $163.9 million in 2026.
• Business Quant data shows STAA's Cash & Current Investments at $163.9 million in Q2 2026, $187.5 million in Q1 2026, and $192.7 million in Q3 2025.